Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene.
Animal, Antigens-Polyomavirus-Transforming: ge, me, Bone-Neoplasms: ge, me, pa, Cell-Line, Cloning-Molecular, Mice, Mice-Transgenic: ge, Osteosarcoma: ge, me, pa, Promoter-Regions-(Genetics), SUPPORT-U-S-GOVT-P-H-S, Tumor-Cells-Cultured: me, pa
Am J Pathol 1990 Aug;137(2):259-62
CA10815/CA/NCI, CA18470/CA/NCI, CA21124/CA/NCI
Mice of a transgenic mouse lineage 501, produced by zygotic injection of the parotid alpha-amylase promoter-SV40 T-antigen hybrid gene, developed osteosarcomas at about 15 months of age. The tumors predominantly involved the axial skeleton, were sometimes multiple, and metastasized to the liver. A cell line derived from a primary tumor produced osteosarcomas on transfer to nude mice. The 501 transgenic lineage thus provides a valuable new model for studying the histogenesis of osteosarcomas.
Knowles, B B.; McCarrick, J; Fox, N; Solter, D; and Damjanov, I, " Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene." (1990). Faculty Research 1990 - 1999. 107.